secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOREGENX, INC. (BRGX)
CIK:        0001593184
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001800943-23-000001
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Findit enters definitive merger with BioRegenx; existing shareholders to hold 10% of voting stock
--------------------------------------------------------------------------------

- BioRegenx shareholders will receive common and preferred shares equivalent to 90% of Findit's voting securities.
- Findit Series A and B preferred shares (98.47% voting control) will be retired into treasury.
- Both parties agree to implement up to a 1-for-25 reverse stock split post-merger.
- Merger expected to close in Q1 2023, subject to shareholder and regulatory approvals.
- Combined entity will be renamed BioRegenx, Inc. and apply for a new ticker symbol.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593184/000180094323000001/0001800943-23-000001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593184/000180094323000001/fdit8k.htm
  HTML page:      https://secwatch.observer/filing/0001800943-23-000001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer